📰 Pharmaceutical Intelligence News
Page 7 - Pharmaceutical Intelligence News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharmaceutical Intelligence. Real-time updates on events, politics, business and more.
July 1, 2023
AGX-148is under clinical development by AgonOx and currently in Phase I for Head And Neck Cancer Squamous Cell Carcinoma.
June 10, 2023
Streptococcus vaccineis under clinical development by Minervax and currently in Phase I for Streptococcal Infections.
June 10, 2023
Crenigacestatis under clinical development by Eli Lilly and Co and currently in Phase I for Chronic Lymphocytic Leukemia (CLL).
June 5, 2023
Vofatamabis under clinical development by Fusion Pharmaceuticals and currently in Phase I for Relapsed Multiple Myeloma.
June 1, 2023
EBI-031is under clinical development by CTx Operations and currently in Phase III for Uveitis.
February 28, 2023
Gene Therapy to Target Lewis Y Antigen for Lung Canceris under clinical development by Bristol-Myers Squibb and currently in Phase I for Lung Cancer.